94. What are the modes of action of prokinetic agents?
L.M.A. Akkermans, AJ.P.M. Smout (Utrecht)

95. Can esophageal acid exposure be reduced by adding a prokinetic agent to an H₂RA?
W. Inauen (Bern)

96. Are the results of the combination of a prokinetic agent with an antisecretory agent affected by tobacco smoking?
B. Fraitag (Paris)

97. What are the respective advantages of the different prokinetic agents at the disposal of the gastroenterologist?
D. Couturier (Paris)

98. What effects have prokinetic agents on the amplitude and duration of esophageal contractions?
D. Couturier (Paris)

99. What are the modalities of prescription of prokinetics in infancy?
Ch. Dupont (Paris)

100. Why do some patients not respond to combined prokinetic-antisecretory treatment?
W. Inauen (Bern)

101. Is it possible to distinguish the categories of esophagitis which will benefit more from prokinetic or from antacid treatment?
G.G. Jamieson (Adelaide)

102. Prokinetic agents of the future: do they have any role in the medical treatment of GERD?
C. Scarpignato, G. Gimbo (Parma)